Idamycin PFS Related Clinical Trials
Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome [Recruiting]
Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes [Recruiting]
E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes [Recruiting]
Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas [Recruiting]
Safety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia [Recruiting]
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML) [Recruiting]
A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia [Recruiting]
Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia [Recruiting]
Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction [Recruiting]
Fludarabine, Cytarabine, Filgrastim and Idarubicin in Core Binding Factor (CBF) Leukemias [Recruiting]
Efficacy and Toxicity of Increasing Doses of Idarubicin, Cytarabine and G-CSF in Acute Myeloid Leukemia [Not yet recruiting]
Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) [Recruiting]
Bendamustine Hydrochloride and Idarubicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia or Myelodysplastic Syndrome [Recruiting]
Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML) [Recruiting]
Phase 1/2 Study of Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) [Recruiting]
Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma [Recruiting]
Clofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML [Recruiting]
Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML [Recruiting]
Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML [Recruiting]
Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia [Not yet recruiting]
Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Completed]
Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia [Recruiting]
Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine [Recruiting]
Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia [Recruiting]
Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML [Completed]
Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) [Recruiting]
HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia [Recruiting]
Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia [Active, not recruiting]
Idarubicin Versus High Dose Daunorubicin in Acute Myelogenous Leukemia (AML) [Recruiting]
VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia [Active, not recruiting]
Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia [Active, not recruiting]
the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient [Recruiting]
Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Recruiting]
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome [Active, not recruiting]
Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia [Completed]
ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML) [Not yet recruiting]
Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes [Recruiting]
Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) [Recruiting]
Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma [Recruiting]
Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma [Active, not recruiting]
Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia [Recruiting]
Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia [Recruiting]
Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia [Recruiting]
A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Recruiting]
Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia [Active, not recruiting]
Autologous Hematopoietic Cell Transplantation for Acute Promyelocytic Leukemia After Relapse With Idarubicin and Busulfan Conditioning [Recruiting]
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML) [Recruiting]
Aezea® (Cenersen) and Chemotherapy for Acute Myelogenous Leukemia Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course [Not yet recruiting]
Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia [Recruiting]
Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML) [Recruiting]
Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) [Completed]
Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [Active, not recruiting]
Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Completed]
Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia [Active, not recruiting]
All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Active, not recruiting]
Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia [Active, not recruiting]
Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma [Active, not recruiting]
Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia [Active, not recruiting]
High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia [Active, not recruiting]
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia [Active, not recruiting]
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia [Active, not recruiting]
Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma [Active, not recruiting]
A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia. [Terminated]
Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia [Recruiting]
Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years [Completed]
SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia [Active, not recruiting]
Lomustine and Intermediate Dose Cytarabine in Older Patients With AML [Completed]
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia [Active, not recruiting]
AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia [Recruiting]
Efficacy of G-CSF-Priming in Elderly AML Patients [Recruiting]
Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Recruiting]
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia [Recruiting]
FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML [Recruiting]
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia [Active, not recruiting]
Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia [No longer recruiting]
Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Lymphoma
Interferon-Alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [Active, not recruiting]
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia [Active, not recruiting]
Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia [Active, not recruiting]
Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia [No longer recruiting]
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma [Recruiting]
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis [No longer recruiting]
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia [Active, not recruiting]
Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result [No longer recruiting]
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99) [Completed]
Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia [Completed]
Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T [Active, not recruiting]
Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [No longer recruiting]
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia [Active, not recruiting]
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia [Active, not recruiting]
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma [Completed]
Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia [Active, not recruiting]
Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome [Active, not recruiting]
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia [Completed]
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia [Active, not recruiting]
|
